Birthweight and Cytochrome P4503A4/5 Activity in Obese Women
Overview
Overview
Authors
Affiliations
Affiliations
Soon will be listed here.
References
1.
McMillen I, Robinson J
. Developmental origins of the metabolic syndrome: prediction, plasticity, and programming. Physiol Rev. 2005; 85(2):571-633.
DOI: 10.1152/physrev.00053.2003.
View
2.
Gunnarsdottir I, Birgisdottir B, Benediktsson R, Gudnason V, Thorsdottir I
. Association between size at birth, truncal fat and obesity in adult life and its contribution to blood pressure and coronary heart disease; study in a high birth weight population. Eur J Clin Nutr. 2004; 58(5):812-8.
DOI: 10.1038/sj.ejcn.1601881.
View
3.
Edelman A, Munar M, Elman M, Koop D, Cherala G
. Effect of the ethinylestradiol/levonorgestrel combined oral contraceptive on the activity of cytochrome P4503A in obese women. Br J Clin Pharmacol. 2012; 74(3):510-4.
PMC: 3477352.
DOI: 10.1111/j.1365-2125.2012.04209.x.
View
4.
Godfrey K, Barker D
. Fetal programming and adult health. Public Health Nutr. 2001; 4(2B):611-24.
DOI: 10.1079/phn2001145.
View
5.
Spriet I, Meersseman W, de Hoon J, von Winckelmann S, Wilmer A, Willems L
. Mini-series: II. clinical aspects. clinically relevant CYP450-mediated drug interactions in the ICU. Intensive Care Med. 2009; 35(4):603-12.
DOI: 10.1007/s00134-008-1383-2.
View